The Immune System – News and Features

News
Salivary Diagnostic Device Shows Promise
Researchers supported by the National Institute of Dental and Craniofacial Research have developed a device that measures proteins in saliva to indicate a developing disease in the mouth or body.

News
Carrington Subsidiary DelSite and Nastech Sign Technology Evaluation Agreement
Nastech to evaluate Carrington's GelSite for potential to enhance intranasal delivery of Nastech's peptide and protein therapeutics in liquid formulations.

News
Novosom Acquires Exclusive Option for Antisense Inhibitors from Isis Pharmaceuticals
The option will provide the Novosom with a worldwide licence to antisense inhibitors targeting the CD40 membrane protein for all indications.

News
Agilent Technologies Signs Agreement to Acquire Stratagene
Agilent signs a definitive agreement to acquire life science research reagents and instruments provider company Stratagene.

News
Scientists Decode Genome of Oral Pathogen
Virginia Commonwealth University researchers have sequenced the genome of a bacteria found in the human mouth that can cause dangerous infections.

News
Fragmenting Bio-Sugars Yields Sweet Structural Information
A research has shown that the application of a mass spectrometry technique to glyconconjugates could lead to understand biological structures and their activity.

News
PharmaStem Patents Confirmed after Reexamination by Patent Office
USPT has confirmed all the claims in PharmaStem’s patents regarding umbilical cord blood stem cells.

News
Immune response to Cancer Stem Cells may Dictate Cancer’s Course
A new study shows that immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease.

News
Generex Biotechnology to Test Novel RNAi-Based Immune-Response Strategy in Cancer Patients
Clinical trials to be conducted in Beijing, China with renowned hematologist.

News
Alnylam and Stanford Scientists Discover Role for miRNAs in T Cell Biology and Immunity
Alnylam and Stanford University’s findings published in the journal Cell show that miR-181a regulates T cell responses to antigens.
Advertisement